New therapeutic target for cancer identified by revealing how cancer 'hijacks' blueprint for blood vessel development

Anti-angiogenic therapies targeting VEGF person been wide utilized successful crab treatment, yet their semipermanent efficacy remains limited. Tumor vascular endothelial cells (TECs) grounds precocious adaptive plasticity, enabling them to defy attraction and prolong tumor growth, but the molecular mechanics underlying this plasticity has remained poorly understood.